🔎 Trials Near Me

Gara Jalqabaatti › Dhibee Parkinson › New York › New York City

Qorannoo klinikaalii Dhibee Parkinson New York City, NY keessatti

Qorannoo 23 Dhibee Parkinson f New York City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Namoota walitti qabaa jiraSadarkaa 2
  • Icahn School of Medicine at Mount Sinai/Mount Sinai West, New York
  • Columbia University, New York
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06680830

Visual Hallucinations in Lewy Body Diseases

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • NYU Langone Health, New York
Umuriin 18 hanga 90 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07849413

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

Namoota walitti qabaa jiraSadarkaa 2/3
  • Site-005, New York
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06976268

GBPDC: Gut-Brain in PD Consortium Master Protocol

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Columbia University, New York
Umuriin 21 hanga 80 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07567794

Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

Namoota walitti qabaa jiraSadarkaa 2
  • Weill Cornell Medical College, New York
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07005180

A Study of Buntanetap in Participants With PD

Namoota walitti qabaa jiraSadarkaa 2/3
  • Mount Sinai Hospital, New York
Umuriin 40 hanga 85 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07284784

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

Namoota walitti qabaa jiraSadarkaa 2
  • Vima Site #024, New York
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07804615

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

Namoota walitti qabaa jiraSadarkaa 2
  • Joan and Sanford I. Weill Department of Medicine (Site #224), New York
  • Mount Sinai School of Medicine (Site #209), New York
Umuriin 30 hanga 80 · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT07432958

Parkinson's Foundation PD GENEration Genetic Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Mount Sinai, New York
  • Columbia University, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT04994015

A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Northwell Health, New York
Umuriin 45 hanga 75 · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07330258

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Namoota walitti qabaa jiraSadarkaa 3
  • Weill Cornell Medical College, New York
  • Columbia University Medical Center, New York
Umuriin 50 hanga 85 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07174310

Young Onset Parkinson's Disease Subtypes and Pathogenic Mechanisms

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • NYU Langone Health, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT07752355

Autoimmune Features of Neurodegenerative Disorders

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Columbia University Medical Center, New York
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT04239079

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

Namoota walitti qabaa jiraSadarkaa 3
  • Mount Sinai West - Neurology, New York
  • New York Presbyterian/Weill Cornell Medical Center, New York
Umuriin 45 hanga 75 · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT06944522

Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease

Namoota walitti qabaa jira
  • Radial Midtown Manhattan, New York
Umuriin 22 hanga 80 · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT07207122

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Beth Israel Medical Center, New York
  • NYU Langone Health, New York
Umuriin 30 fi ol · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT04477785

Natural History Study of Synucleinopathies

Namoota walitti qabaa jiraQorannoo ilaalaa
  • NYU Medical Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT01799915

Parkinson's Disease Biomarkers in Nerve Cells in the Gut

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Weill Cornell Medicine, New York
Umuriin 45 hanga 75 · Saalaa hunda · Haaromfame 22-Cam-2026 · NCT05347407

This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.

Namoota walitti qabaa jiraSadarkaa 1/2
  • Cornell University Weill Medical College, New York
Umuriin 30 hanga 75 · Saalaa hunda · Haaromfame 11-Cam-2026 · NCT07102342

A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Weill Cornell Medicine, New York
Umuriin 30 hanga 99 · Saalaa hunda · Haaromfame 20-Bit-2026 · NCT05539196

A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease

Namoota walitti qabaa jiraSadarkaa 1/2
  • New York Presbyterian Hospital-Columbia University Medical Center, New York
Umuriin 40 hanga 72 · Saalaa hunda · Haaromfame 02-Bit-2026 · NCT06753331

NYSCF Scientific Discovery Biobank

Namoota walitti qabaa jiraQorannoo ilaalaa
  • New York Stem Cell Foundation Research Institute, New York
30 Days · Saalaa hunda · Haaromfame 03-Bit-2025 · NCT06203106

Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease

Namoota walitti qabaa jiraSadarkaa jalqabaa 1
  • Teachers College, Columbia University, New York
Umuriin 50 hanga 80 · Saalaa hunda · Haaromfame 15-Hag-2024 · NCT06540989

Qorannoo Dhibee Parkinson magaalota biroo keessatti

Qorannoo biroo New York City keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.